Radiotherapeutic self-propelled nanobots shrink bladder tumors 90% in mice
GEN News - 15-Jan-2024New, more efficient approach for personalized bladder cancer treatment
Join the club for FREE to access the whole archive and other member benefits.
Principal investigator, Head of Radiochemistry at CIC biomaGUNE
Jordi Llop is an independent group leader at the Molecular Imaging Unit of CIC biomaGUNE. He has a multidisciplinary training and track record of experience in different disciplines, including chemistry, radiochemistry, in vivo imaging, and nanotechnology.
His early training focused on the synthesis and characterisation of metallic complexes incorporating polyhedral heteroboranes (boron clusters). Post-doctoral appointments (at Navarra University and at Uppsala University PET Centre) and industrial experience at IAT-PRBB provided the opportunity to conduct clinical and pre-clinical drug-development research, gain experience of different in vivo imaging modalities and actively interact with big pharmaceutical companies.
Visit website: http://personal.cicbiomagune.es/jllop/
See also: CIC biomaGUNE - Non-profit research center based in San Sebastián, Spain
Details last updated 19-Mar-2021
New, more efficient approach for personalized bladder cancer treatment
Urease-fueled nanorobots with medical imaging tracker is a breakthrough in biomedical research